Pulmonary biomarkers of bronchopulmonary dysplasia

Biomarker Insights

Volumn 2008, Issue 3, 2008, Pages 361-373

  Thompson, Alecia ^a   Bhandari, Vineet ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokins; Lung; Premature neonate

Indexed keywords

3 CHLOROTYROSINE; ANGIOPOIETIN 2; ARTIFICIAL LUNG SURFACTANT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA CHEMOKINE; BIOLOGICAL MARKER; CAFFEINE; CATHEPSIN K; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLARA CELL PROTEIN; DIURETIC AGENT; FIBRONECTIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 16; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LACTOFERRIN; LYSOZYME; MACROPHAGE MIGRATION INHIBITION FACTOR; MALONALDEHYDE; MONOCYTE CHEMOTACTIC PROTEIN; OXYGEN; RETINOL; STEROID; TUMOR NECROSIS FACTOR;

ARTIFICIAL VENTILATION; BAROTRAUMA; CELL TYPE; CHORIOAMNIONITIS; CHRONIC RESPIRATORY TRACT DISEASE; DIAGNOSTIC VALUE; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE PREDISPOSITION; FIBRINOLYSIS; FLUID INTAKE; GENETIC PREDISPOSITION; HUMAN; HYPEROXIA; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG FIBROSIS; NECROTIZING ENTEROCOLITIS; NEWBORN MORBIDITY; NEWBORN MORTALITY; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PNEUMONIA; PREDICTION; PREMATURITY; REVIEW; RISK FACTOR; SEPSIS; THORAX RADIOGRAPHY; TISSUE REPAIR;

EID: 50049088570     PISSN: None     EISSN: 11772719     Source Type: Journal    
DOI: 10.4137/bmi.s834     Document Type: Review

References (60)

1. Bhandari, A. and Bhandari, V. 2007. Bronchopulmonary dysplasia: an update. Indian J. Pediatr., 74:73-7.
2. Speer, C. 2006. Inflammation and bronchopulmonary dysplasia: a continuing story. Semin. Fetal Neonatal. Med., 11:354-62.
3. Kallapur, S. and Jobe, A. 2006. Contribution of inflammation to lung injury and development. Arch. Dis. Child Fetal Neonatal. Ed., 91:132-5.
4. Bourbon, J., Boucherat, O., Chailley-Heu, B. and Delacourt, C. 2005. Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia. Pediatr. Res., 57:38-46.
5. Jobe, A. and Ikegami, M. 1998. Mechanisms initiating lung injury in the preterm. Early Hum. Dev., 53:81-94.
6. Agrons, A., Courtney, S., Stocker, J. and Markowitz, R. 2005. From the archives of the AFIP: Lung disease in premature neonates: radiologic-pathologic correlation. Radiographics, 25:1047-73.
7. Tayal, V., and Kalra, B.S. 2008. Cytokines and anti-cytokines - an update. Eur. J. Pharmacol., 579:1-12.
8. Cordero, L., Sananses, M., Dedhiya, P. and Ayers, L.W. 2001.Purulence Purulence and gram-negative bacilli in tracheal aspirates of mechanically ventilated very low birth weight infants. J. Perinatol., 21:376-81.
9. Ryan, R., Ahmed, Q. and Lakshminrusimha, S. 2008. Inflammatory mediators in the immunology of bronchopulmonary dysplasia. Clinic Rev. Allergy Immunol., 34:174-90.
10. Speer, C.P. 2004. Pre.- and postnatal inflammatory mechanisms in chronic lung disease of preterm infants. Pediatr. Resp. Reviews, 5:S241-4.
11. Bhandari, V., Bizzarro, M., Shetty, A., Zhong, X., Page, G., Zhang, H., Ment, L. and Gruen, J. 2006. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics., 117:1901-6.
12. Bokodi, G., Treszl, A., Kovacs, L., Tulassay, T. and Vasarhelyi, B. 2007. Dysplasia: a review. Pediatr. Pulmonol., 42:952-61.
13. Viscardi, R., Muhumuza, C., Rodriquez, A., Fairchild, K., Sun, C., Gross, G., Campbell, A., Wilson, P., Hester, L. and Hasday, J. 2004. Inflammatory markers in intrauterine-anfd fetal blood and cerebro-spinal fluid compartments. Pediatr. Res., 55:1009-17.
14. Watterberg, K., Demers, L., Scott, S. and Murphy, S. 1996. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics, 97:210-5.
15. Van Marter, L., Dammann, O., Allred, E., Leviton. A., Pagano, M., Moore, M. and Martin, C. 2002. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J. Pediatr. 140:171-6.
16. Gianluca, L., Castoldi, F., Fontana, P., Reali, R., Reggiani, A., Bianchi, S. and Compagnoni, G. 2006. Lung inflammation in preterm infants with respiratory distress syndrome: effects of ventilation with different tidal volume. Pediatr. Pulmonol., 357-63.
17. Bhandari, V., Choo-Wing, R., Lee, C.G., Zhu, Z., Nedrelow, J.H., Chupp, G.L., Zhang, X., Matthay, M.A., Ware, L.B., Homer, R.J., Lee, P.J., Geick, A., de Fougerolles AR and Elias, J.A. 2006. Hyperoxia causes angiopoietin-2 mediated acute lung injury and necrotic cell death. Nat. Med., 12:1286-93.
18. Bhandari, V. and Elias, J.A. 2006. Cytokines in tolerance to hyperoxia-indiced injury in the developing and adult lung. Free Radic. Biol. Med., 41:4-18.
19. D'Angio, C., Basavegowda, K., Avissar, N., Finkelstein, J. and Sinkin, R. 2002. Comparison of tracheal aspirates and bronchoalveolar lavage specimens from premature infants. Biol. Neonate., 82:144-9.
20. Tullus, K., Noack, G., Burman, L., Nilsson, R., Wretlind, B. and Brauner, A. 1996. Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia. Eur. J. Pediatr., 155:112-6.
21. Choi, C.W., Kim, B.I., Kim, H., Park, J.D., Choi, J.-H. and Son, D.W. 2006. Increase of interleukin-6 in tracheal apsirate at birth: a predictor of subsequent bronchopulmonary dysplasia in preterm infants. Acta. Pediatrica., 95:38-43.
22. Vento, G., Capoluongo, E., Matassa, P.G., Concolino, P., Vendettuoli, V., Vaccarella, C., Frezza, S., Zuppi, C., Romagnoli, C. and Ameglo, F. 2006. Serum levles of seven cytokines in premature, ventilated newborns, correlation wirh old and new forms of bronchopulmonary dysplasia. Intensive Care Med., 32:723-30.
23. Kotecha, S., Wilson, L., Wangoo, A., Silverman, M. and Shaw, R. 1996. Increases in interleukin (IL)-1 and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr. Res., 40:250-6.
24. Munshi, U.K., Niu, J.O., Siddiq, M.M. and Parton, L.A. 1997. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr. Pulmonol., 24:331-6.
25. Kazzi, S., Romero, R., McLaughlin, K., Ager, J, and James, J. 2001. Serial changes in levels of IL-6 and IL-1 in premature infants at risk for bronchopulmonary dysplasia. Pediatr. Pulmonol., 220-6.
26. De Dooy, J., Leven, M., Stevens, W., De Clerck, L. and Mahieu, L. 2007. High levels of CXCL8 in tracheal aspirate samples taken at birth are associated with adverse respiratory outcome only in preterm infants younger than 28 weeks gestation. Pediatr. Pulmonol., 42:193-203.
27. Jonsson, B., Tullus, K., Brauner, A., Lu, Y. and Noack, G. 1997. Early increase of TNF and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants. Arch. Dis. Child., 77:F198-201.
28. Wang, H., Oei, J., Lui, K. and Henry, R. 2002. Interleukin-16 in tracheal aspirate fluids of newborn infants. Early Hum. Dev., 67:79-86.
29. Oei, J., Lui, K., Wang, H. and Henry, R. 2002. Decreased interleukin-10 in tracheal aspirates from preterm infants developing chronic lung disease. Acta. Pediatr., 91:1194-9.
30. McColm, J., Stenson, B., Biermasz, N. and McIntosh, N. 2000. Measurement of interleukin 10 in bronchoalveolar lavage from preterm ventilated infants. Arch. Dis. Child Fetal. Neonatal. Ed., 82:156-9.
31. Garingo, A., Tesoriero, L., Cayabyab, R., Durand, M., Blahnik, M., Sardesai, S.,Ramanathan, R., Jones, C., Kwong, K., Li, C. and Minoo, P. 2007. Constitutive IL-10 Expression by lung inflammatory cells and risk for bronchopulmonary dysplasia. Pediatr. Res., 61:197-202.
32. Baier, R., Loggins, J. and Kruger, T. 2003. Interleukin-4 and 13 concentrations in infants at risk to develop bronchopulmonary dysplasia. BMC Pediatr., 3.
33. Aghai, Z., Faqiri, S., Saslow, J., Nakhla, T., Farhath, S., Kumar, A., Eydelman, R., Strande, L., Stahl, G., Leone, P. and Bhandari, V. 2008. Angiopoietin 2 concentrations in infants developing bronchopulmonary dysplasia: attenuation with dexamethasone. J. Perinatol., 28:148-55.
34. Knappi, J., Lukkarinen, H., Kiviranta, R., Steiner, A., Lassus, P., Andersson, S. and Kaapa, P. 2006. Cathepsin K expression in diminished in infants with bronchopulmonary dysplasia. Acta. Pediatrica, 95:1298-305.
35. Baier, J., Majid, A., Parupia, H., Loggins, J. and Kruger, T. 2004. CC chemokine concentrations, increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia. Pediatr. Pulmonol., 37:137-48.
36. Lassus, P., Nevalainen, T., Eskola, J. and Andersson, S. 2000. Clara-cell secretory protein in preterm ifnants' tracheal aspirates correlates with maturity and increases in infection. Pediatr. Pulmonol., 30:466-9.
37. Ramsay, P., DeMayo, F., Hegemier, S., Wearden, M., Smith, C. and Welty, S. 2001. Clara cell secretory protien oxidation and expression in premature infants who develop brocnhopulmonary dysplasia. Am. J. Resp. Crit. Care Med., 164:155-61.
38. Buss, H.I., Senthilmohan, R., Darlow, B.A., Mogridge, N., Kettle, A.J. and Winterbourn, C.C. 2003. 3-Chlorotyrosine as a marker of protien damage by myeloperoxidase in tracheal aspirates from preterm infants: association with adverse respiratory outcome. Pediatr. Res., 53:455-62.
39. Watts, C., Fanaroff, A. and Bruce, M. Elevation of fibronectin levels in lung secretions of infants with repsiratory distress syndrome and development of bronchopulmonary dysplasia. J. Pediatr., 120:614-20.
40. Revenis, M. and Kaliner, M. 1992. Lactoferrin and lysozyme deficiency in airway secretions: association with the development of bronchopulmonary dysplasia. J. Pediatr., 121:262-70.
41. Kevill, K., Bhandari, V., Kettunen, M., Lenq, L., Fan, J., Mizue, Y., Dziura, J., Reves-Mujica, M., Mcdonald, C., Baugh, J., O'Connor, C., Aghai, Z., Donnelly, S., Bazzy-Asaad, A. and Bucala, R. 2008. A role for macrophage migration inhibitory factor in the neonatal respiratory distress syndrome. J. Immunol., 180:601-8.
42. Collard, K., Godeck, S., Holley, J. and Quinn, M. 2004. Pulmonary antioxidant concentrations and oxidative damage in ventilated premature babies. Arch. Dis. Child Fetal. Neonatal. Ed., 89:412-6.
43. Cederqvist, K., Sorsa, T., Tervahartiala, T., Maisi, P., Reunanen, K., Lassus, P. and Andersson, S. 2001. Matrix Metalloproteinases-2, -8,-9 and TIMP in tracheal aspirates from preterm infants with respiratory distress. Pediatrics, 108:686-92.
44. Bourbia, A. and Cruz, M. Rozycki H 2006 NF- in tracheal lavage fluid from intubated premature infants: association with inflammation, oxygen and outcome. Arch. Dis. Child Fetal. Neonatal. Ed., 91:F36-9.
45. Torday, J., Torres, E. and Rehan, V. 2003. The role of fibroblast transdifferentiation in lung epithelial cell proliferation, differentiation, and repair in vitro. Pediatr. Pathol. Mol. Med., 22.
46. Rehan, V. and Torday, J. 2003. Hyperoxia augments pulmonary lipofibroblast-to-myofibroblast transdifferentiation. Cell Biochem. Biophys., 38:239-50.
47. Rehan, V. and Torday, J. 2006. Lower parathyroid hormone related protein content of tracheal aspirates in very low birth weight infants who develop bronchopulmonary dysplasia. Pediatr. Res., 60:216-20.
48. Cederqvist, K., Siren, V., Petaja, J., Vaheri, A., Haglund, C. and Andersson, S. 2006. High concentrations of plasminogen activator inhibitor-1 in lungs of preterm infants with respiratory distress syndrome. Pediatrics. 117:1226-34.
49. Cederqvist, K., Haglund, C., Heikkila, P., Sorsa, T., Tervahartiala, T., Stenman, U. and Andersson, S. 2003. Pulmonary Trypsin-2 in the development of bronchopulmonary dysplasia in preterm infants. Pediafrics, 112:570-7.
50. Kojima, T., Sasai, M. and Kobayashi, Y. 1993. Increased soluble ICAM-1 in tracheal aspirates of infants with bronchopulmonary dysplasia. Lancet., 342:1023-4.
51. Kotecha, S., Wangoo, A., Silverman, M. and Shaw, R. 1996. Increase in the concentration of transforming growth factor beta-1 in branchoalveolar lavage fluid before development of chronic lung disease of prematurity. J. Pediatr., 128:464-9.
52. Ambalavanan, N. and Novak, Z. 2003. Peptide growth factors in tracheal aspirates of mechanically ventilated preterm neonates. Pediatr. Res., 53:240-4.
53. Kojima, T., Isozaki-Fukuda, Y., Takedatsu, M., Ono, A., Hirata, Y. and Kobayashi, Y. 1992. Palsma endothelin-1 like immunoreactivity in neonates. Eur. J. Pediatr., 151:913-5.
54. Niu, J.O., Munshi, U., Siddiq, M. and Parton, L.A. 1998. Early increase in endothelin-1 in tracheal aspirates of preterm infants:correlation with bronchopulmonary dysplasia. J. Pediatr., 132:965-70.
55. Presta, M., Dell'Era, P., Mitola, S., Moroni, E., Ronca, R. and Rusnati, M. 2005. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev., 16:159-78.
56. Danan, C., Franco, M., Jarreau, P., Dassieu, G., Chailley-Heu, B., Bourbon, J. and Delacourt, C. 2002. High concentrations of keratinocyte growth factor in airways of premature infants predicted absence of bronchopulmonary dysplasia. Am. J. Respir Crit. Care Med., 165:1384-7.
57. Lassus, P., Heikkila, P., Andersson, L., Boguslawski, V. and Andersson, S. 2003. Lower concentration of pulmonary hepatocyte growth factor is associated with more severe lung disease in preterm infants. J. Pediatr., 143:199-202.
58. Thebaud, B. and Abman, S. 2007. Bronchopulmonary dysplasia- where have all the vessels gone? Role of angiogenic growth factors in chronic lung disease. Am. J. Respir. Crit. Care Med., 175:978-85.
59. Lassus, P., Ristimaki, A., Ylikorkala, O., Viinikka, L. and Andersson, S. 1999. Vascular endothelial growth factor in human preterm lung. Am. J. Respir. Crit. Care Med., 159:1429-33.
60. Bhandari, V., Choo-Wing, R., Lee, C.G., Yusuf, K., Nedrelow, J.H., Ambalavanan, N., Malkus, H., Homer, R.J. and Elias, J.A. 2008. Developmental Regulation of NO-mediated VEGF-induced Effects in the Lung. Am. J. Respir. Cell. Mol. Biol., Epub ahead of print.